Tuttle Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Tuttle Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-69,024	Closed	-$20.7K	–	78
2023 Q4	$20.7K	Hold	69,024	–	–	0.14%	39
2023 Q3	$24.1K	Hold	69,024	–	–	0.16%	43
2023 Q2	$11K	Hold	69,024	–	–	0.05%	49
2023 Q1	$10K	Hold	69,024	–	–	0.07%	36
2022 Q4	$3.45K	Hold	69,024	–	–	0.01%	62
2022 Q3	$3K	Hold	69,024	–	–	0.01%	89
2022 Q2	$8K	Hold	69,024	–	–	0.02%	97
2022 Q1	$12K	Hold	69,024	–	–	0.03%	89
2021 Q4	$22K	Buy	+69,024	New	+$21.8K	0.03%	106

Tuttle Capital Management's DMAQR Position: Q1 2024 in Review

Tuttle Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 69,024 shares — an estimated $20.7K sold.

Tuttle Capital Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $24.1K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Tuttle Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Tuttle Capital Management sold 69,024 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $20.7K.
Tuttle Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Tuttle Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $24.1K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Tuttle Capital Management's 13F filing for Q1 2024, filed 11 Apr 2024.